SCHEMBL6034907

SCHEMBL6034907

O=C(CCCCNCCc1ccccc1Cl)c1ccc2c(c1)NS(=O)(=O)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.40
CHRM2 P08172 1/20 0.39
PLAAT3 P53816 2/20 0.37
PLAAT5 Q96KN8 2/20 0.37
PLAAT2 Q9NWW9 2/20 0.37
PLAAT4 Q9UL19 2/20 0.37
MAPT P10636 1/20 0.37
TRPV1 Q8NER1 1/20 0.35
SLC2A1 P11166 1/20 0.35
P2RX7 Q99572 2/20 0.35
ACHE P22303 1/20 0.35
CNR1 P21554 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
KMT2A Q03164 2/20 0.34
FOLH1 Q04609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5983675 0.99 HIF1A (0.39) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
SCHEMBL6034918 0.92 HIF1A (0.40) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
Hydrochloric Acid SCHEMBL5983686 0.91 HIF1A (0.39) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
SCHEMBL13987733 0.86 ACHE (0.37) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
Hydrochloric Acid SCHEMBL4881991 0.86 ACHE (0.37) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
SCHEMBL27593313 0.85 HIF1A (0.41) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
Hydrochloric Acid SCHEMBL4882003 0.80 ACHE (0.37) HIF1ACHRM2PLAAT3PLAAT5PLAAT2
SCHEMBL6035904 0.79 ALDH1A1 (0.56) MAPTKMT2ATP53MEN1
SCHEMBL6035065 0.78 HDAC3 (0.49) HIF1AACHEHDAC3HDAC1HDAC2
SCHEMBL6036029 0.78 GPR84 (0.45) HIF1ACHRM2PLAAT3PLAAT5PLAAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060063769-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-03-23 US claimed
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063769-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 HIF1A 2216/4885CHRM2 9/4885PLAAT3 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.